Osteotech, Inc. engages in processing and distributing allograft bone tissue used for transplantation. It operates in two segments, Demineralized Bone Matrix (DBM) and Base Allograft Bone Tissue (Base Tissue). The DBM segment engages in processing and marketing Grafton DBM, which is processed from allograft bone tissue recovered by tissue banks and tissue recovery organizations. It also processes private label DBMs. The Base Tissue segment processes bone tissue primarily into mineralized weight-bearing tissue forms. It offers a proprietary line of Graftech Bio-implants and other weight-bearing traditional tissues, which include femoral cross sections, fibula wedges, and cortical struts....